Ride to

save lives.

Join the American Association for Cancer Research (AACR) for a day of energy and empowerment. Revolutions for Research brings together cyclists of all experience levels for over three hours of continuous indoor cycling - ride solo or as a team! Raise money from your personal network to sponsor comprehensive and cutting edge cancer research. Let’s get moving and #pedaltobeatcancer!



Why Ride?

[2016-03-08, 9:51:47 AM] heidim.artez: Source: American Association for Cancer Research [2016-03-08, 9:51:56 AM] heidim.artez: (AACR) Cancer Progress Report 2015

Source: American Association for Cancer Research (AACR) Cancer Progress Report 2015



How It Works

Start or Join a Team

You have what it takes! Whether you’re an indoor cycling pro or have been meaning to try it for the first time, this is your moment.

Raise Money

Use your team’s personal fundraising page to get as many people as possible to sponsor your ride.

The Event

Continue to raise money up to the day of your ride, then it’s time to show up and sweat!


October 6, 2018

Site: The Fillmore, Philadelphia, PA



We are on a mission.

The American Association for Cancer Research (AACR) raises funds to cure ALL of the more than 200 types of cancer. As the world’s first and largest cancer research organization, founded in 1907, the AACR works with institutions and scientists in over 100 countries to understand, prevent, and eradicate every type of cancer. In the last 15 years, the AACR has provided over $200 million in grants to ensure that the world is moving towards being cancer-free. We are dedicated to fundraising in innovative ways and to making sure that the maximum amount of each donation goes directly to cancer research.


Your generous donations help us:
  • Raise awareness and promote understanding of cancer and cancer research.
  • Ensure that researchers have access to cutting-edge technology and all resources necessary to fight cancer aggressively.
  • Develop educational and professional opportunities for future generations of cancer researchers.